Auxly Cannabis Group (CVE:XLY – Get Rating) had its target price decreased by research analysts at Raymond James from C$0.65 to C$0.40 in a research note issued to investors on Friday, BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. Raymond James’ target price indicates a potential upside of 2.56% from the […]
Auxly Cannabis Group Inc. (TSE:XLY – Get Rating) – Raymond James upped their Q3 2022 EPS estimates for shares of Auxly Cannabis Group in a research note issued to investors on Monday, March 28th. Raymond James analyst R. Sarugaser now expects that the company will post earnings per share of $0.00 for the quarter, up […]
Zymergen (NASDAQ:ZY – Get Rating) and Auxly Cannabis Group (OTCMKTS:CBWTF – Get Rating) are both small-cap basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, valuation, profitability, risk and dividends. Profitability This table compares Zymergen and Auxly Cannabis […]